Who has invested in Coave Therapeutics?

Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, Omnes Capital, V-Bio Ventures are named among the investors backing Coave Therapeutics.

Coave Therapeutics Funding: $39M Raised, Series B (2021)

Coave Therapeutics funding overview

Coave Therapeutics is a Biotech company based in Paris, France. Coave Therapeutics has raised $39M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2021. The round record for Coave Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, Omnes Capital, V-Bio Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.

Coave Therapeutics at a glance

Total raised: $39M
Latest round: Series B
Latest round date: July 2021
Industry: Biotech
Headquarters: Paris, France
Notable investors: Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, Omnes Capital, V-Bio Ventures, Kurma Partners, Idinvest

Frequently asked about Coave Therapeutics funding

How much has Coave Therapeutics raised?: Coave Therapeutics has raised $39M in total disclosed funding across the rounds on record.
Who has invested in Coave Therapeutics?: Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, Omnes Capital, V-Bio Ventures are named among the investors backing Coave Therapeutics.
What was the latest Coave Therapeutics funding round?: The most recent disclosed round is a Series B, announced in July 2021.
Where is Coave Therapeutics based?: Coave Therapeutics is based in Paris, France.
What sector does Coave Therapeutics operate in?: Coave Therapeutics is tracked under Biotech from Paris, France, with $39M in disclosed funding.
When did Coave Therapeutics last raise?: The last disclosed Coave Therapeutics round closed in July 2021 at Series B.

Coave Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Paris below to benchmark round size and investor mix.

Coave Therapeutics Funding: $39M Raised, Series B (2021)

Coave Therapeutics funding overview

Coave Therapeutics at a glance

Frequently asked about Coave Therapeutics funding

Coave Therapeutics founders (1)

Companies related to Coave Therapeutics (40)

Browse related funding lists (8)